Darrell Drennan
About Darrell Drennan
Title
Darrell Drennan is the Vice President and Head of Global Supply Planning at Bristol-Myers Squibb in New Jersey. He also currently holds the position of Head, Biologic Supply Planning at the same company in New Brunswick, NJ.
Professional Background
Darrell Drennan possesses over 20 years of experience across various industries, including biopharma, consulting, high tech, and the U.S. Navy. His background includes notable roles such as Vice President of Supply Chain Management at Juno Therapeutics, Inc., Director of Global Operations at Amgen, and a Submarine Naval Officer in the U.S. Navy. He has been pivotal in roles requiring strategic planning and high-level operational leadership.
Experience at Bristol-Myers Squibb
Darrell Drennan has held multiple positions at Bristol-Myers Squibb, demonstrating his versatility and leadership within the company. From 2011 to 2014, he served as Executive Director, Strategic Product Leader, Therapeutic Area Lead & Global Launch Excellence. He then became Head, Biologics Immuno-Oncology Product Strategy from 2014 to 2016. Currently, he serves as Vice President, Head of Global Supply Planning and Head, Biologic Supply Planning in New Brunswick, NJ. He led the integration of a global supply planning team, streamlining end-to-end design and simplifying execution.
Education and Expertise
Darrell Drennan holds a BSE in Mechanical Engineering & Material Science from Duke University and an MBA from the University of Colorado Denver. His expertise includes GMP/cGMP Operations, Process Improvement, Six Sigma methodologies, Sales & Operations Planning (S&OP), and Demand & Supply Planning. Additionally, he has a strong background in matrix team leadership and has been effective in managing cross-functional teams.
Achievements
Throughout his career, Darrell Drennan has been known for building high performing teams and driving organizational change. He has a track record of streamlining operations and increasing productivity. His efforts in integrating global supply planning teams at Bristol-Myers Squibb have significantly improved the efficiency of end-to-end design and execution. He is also recognized for his strategic contributions towards long-term business goals.